Gain Therapeutics (GANX) Current Taxes (2020 - 2026)
Gain Therapeutics (GANX) posted quarterly Current Taxes of $66674.0 for Q1 2026, up 270.97% year-over-year from $17973.0 in Q1 2025, and up 54.74% quarter-over-quarter from $43089.0 in Q4 2025.
Gain Therapeutics (GANX) Current Taxes (2020 - 2026) Analysis & Trends
Gain Therapeutics' Current Taxes history runs 7 years deep, the most recent figure standing at $66674.0 for Q1 2026.
- In Q1 2026, Current Taxes rose 270.97% year-over-year to $66674.0; the TTM figure through Mar 2026 stood at $66674.0 (up 270.97% YoY), while the FY2025 annual figure was $43089.0, up 133.0% from the prior year.
- Current Taxes for Q1 2026 stood at $66674.0, up from $43089.0 in the prior quarter.
- The five-year high for Current Taxes was $184693.0 in Q2 2023, with the low at $2035.0 in Q1 2022.
- The 5-year median for Current Taxes is $46289.0 (2025), against an average of $54061.9.
- The sharpest annual moves came in 2022 and 2025: Current Taxes surged 28139.74% in 2022, then plunged 75.93% in 2025.
- Gain Therapeutics' Current Taxes stood at $107311.0 in 2022, then plunged by 54.37% to $48965.0 in 2023, then plunged by 62.23% to $18493.0 in 2024, then jumped by 133.0% to $43089.0 in 2025, then soared by 54.74% to $66674.0 in 2026.
- Business Quant data shows GANX's Current Taxes at $66674.0 in Q1 2026, $43089.0 in Q4 2025, and $46289.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.36 Mn |
| 10 | Gain Therapeutics | 85.12 Mn | 85.12 Mn | - | 69,689.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69,689.00 |
| Mar 31, 2026 | 66,674.00 |
| Dec 31, 2025 | 43,089.00 |
| Sep 30, 2025 | 46,289.00 |
| Jun 30, 2025 | 25,169.00 |
| Mar 31, 2025 | 17,973.00 |
| Dec 31, 2024 | 18,493.00 |
| Sep 30, 2024 | 21,001.00 |
| Jun 30, 2024 | 49,735.00 |
| Mar 31, 2024 | 74,680.00 |
| Dec 31, 2023 | 48,965.00 |
| Sep 30, 2023 | 69,257.00 |
| Jun 30, 2023 | 184,693.00 |
| Mar 31, 2023 | 120,783.00 |
| Dec 31, 2022 | 107,311.00 |
| Sep 30, 2022 | 12,847.00 |
| Jun 30, 2022 | 10,059.00 |
| Mar 31, 2022 | 2,035.00 |
| Dec 31, 2021 | 380.00 |
| Sep 30, 2021 | 10,478.00 |